|
Volumn 39, Issue 2 Suppl 1, 2002, Pages 22-26
|
Expanding the use of arsenic trioxide: leukemias and beyond.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
ORGANOARSENIC DERIVATIVE;
OXIDE;
APOPTOSIS;
DRUG EFFECT;
HUMAN;
LEUKEMIA;
MULTIPLE MYELOMA;
NEOPLASM;
PROMYELOCYTIC LEUKEMIA;
REVIEW;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
ARSENICALS;
HUMANS;
LEUKEMIA;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MULTIPLE MYELOMA;
NEOPLASMS;
OXIDES;
MLCS;
MLOWN;
|
EID: 0036551428
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: 10.1053/shem.2002.33611 Document Type: Review |
Times cited : (79)
|
References (27)
|